Bioactive Fluid Compositions for Endothelial Cell Survival
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current crystalloid fluids used for intravenous fluid replacement exacerbate endothelial cell injury, leading to vascular leakage, tissue damage, and organ injury, and fail to maintain endothelial cell integrity, resulting in adverse clinical outcomes.
Innovation Solution
Bioactive fluid compositions containing specific amino acids, electrolytes, and antioxidants are formulated to promote endothelial cell survival and integrity, reducing extravasation and improving tissue oxygen perfusion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stress or pressure
If crystalloid fluids are infused to restore intravascular volume, then blood volume and blood pressure increase transiently, but endothelial cell integrity is exacerbated and vascular leakage increases
Solution Approach 1:
The patent introduces bioactive additives (amino acids, vitamins, trace elements, antioxidants) as intermediary substances that mediate between the crystalloid fluid and endothelial cells. These additives protect endothelial cells from injury while allowing the fluid to maintain its volume expansion function, thus resolving the contradiction between raising blood pressure and protecting endothelial integrity
Solution Approach 2:
The patent creates a composite fluid composition by combining traditional crystalloid fluids with bioactive additives. This composite formulation maintains the volume-expanding properties of crystalloids while adding protective and restorative functions through the bioactive components, thereby achieving both blood pressure support and endothelial protection
2Volume of moving object
If large volumes of crystalloid fluid are infused to restore intravascular volume, then blood volume increases, but hemodilution and depletion of energy stores occur
Solution Approach 1:
The patent incorporates energy stores and metabolites into the fluid composition as copies or representations of the body's natural energy currency. By including these substances directly in the fluid, the body can replenish energy stores without requiring large volumes of pure crystalloid fluid, thus reducing hemodilution while maintaining volume expansion
Solution Approach 2:
The patent modifies the compositional parameters of the fluid by adding bioactive additives that provide energy and metabolic support. This changes the fluid from a simple volume expander to a multifunctional solution that also supports cellular metabolism, allowing smaller volumes to achieve both volume restoration and energy replenishment
3Volume of moving object
If crystalloid fluids are used for fluid replacement, then intravascular volume increases, but fluid extravasation and accumulation in surrounding tissues occurs
Solution Approach 1:
The patent introduces bioactive additives as intermediary substances that stabilize the vascular endothelium and prevent fluid leakage. These additives act as protective mediators that maintain vascular integrity during fluid infusion, thereby preventing extravasation while allowing intravascular volume expansion to occur
Solution Approach 2:
The patent uses short-chain amino acids and small bioactive molecules as disposable protective agents that can be rapidly metabolized or excreted. These lightweight bioactive components provide immediate vascular protection during infusion and are quickly cleared from the system, preventing prolonged effects while maintaining intravascular volume
Data Source
AI summary
This disclosure relates to bioactive fluid compositions and methods of using the compositions. The bioactive fluid compositions can be used for intravenous administration in place of conventional crystalloid fluid compositions.